Clinikally

Emerging

Gurugram India YC S22 dermatology telemedicine at $9.9M revenue 2024 with 1.5M customers; $3.1M total ($2.6M Tribe/Goodwater/Sequoia seed Sep 2023) competing with Practo for India digital dermatology care.

Customers
1.5M

Company Overview

About Clinikally

Clinikally is a Gurugram, India-based dermatology telemedicine and online pharmacy platform — backed by Y Combinator (S22) with $3.1 million in total funding including a $2.6 million seed in September 2023 led by Tribe Capital with Goodwater Capital, Sequoia Capital, and Rebel Fund — providing 1.5 million customers with integrated dermatological consultations, AI-assisted skin analysis, and prescription delivery for skin and hair conditions through a digital-first model that democratizes access to dermatology care across India. Founded in 2022 by Arjun Soin, Clinikally achieved $9.9 million in revenue in 2024 with a 76-person team, addressing the significant dermatology care access gap in a country where there are fewer than 10,000 dermatologists for 1.4 billion people.

Business Model & Competitive Advantage

Clinikally's integrated dermatology platform addresses the specialty care access problem that characterizes Indian healthcare: seeing a dermatologist in India typically requires waiting weeks for an appointment at a clinic in a major city — most patients with treatable skin conditions (acne, eczema, psoriasis, fungal infections, hair loss) either self-treat inadequately with over-the-counter products, receive inappropriate treatment from general practitioners unfamiliar with dermatological diagnosis, or go untreated. Clinikally's telemedicine model (patients uploading skin photos and describing symptoms, board-certified dermatologists providing consultations asynchronously or through live video, and prescriptions fulfilled through Clinikally's online pharmacy for same-day or next-day delivery) provides the specialist access quality at the convenience and cost of a pharmacy visit — making dermatology care available to patients throughout India who cannot access urban clinics.

Competitive Landscape 2025–2026

In 2025, Clinikally competes in the India telemedicine, dermatology care, and digital health pharmacy market with Practo (NASDAQ adjacent Indian healthtech, $120M raised), Derma Co (dermatology brand, part of The Good Glamm Group), and MFine (AI health platform, $48M raised) for Indian consumer dermatology telemedicine and prescription skincare platform adoption. Tribe Capital's and Sequoia Capital's investments reflect high conviction in India digital health consumer growth. Y Combinator S22 backing connects Clinikally with the global digital health investment community. The $9.9M revenue at $3.1M total raised represents exceptional capital efficiency. The 2025 strategy focuses on expanding geographic coverage beyond metro areas to Tier 2 and Tier 3 Indian cities (where dermatology access is worst), building the AI dermatology diagnostic tool for preliminary skin condition assessment, and growing the branded skincare product line for ongoing dermatologist-recommended treatment.

Revenue
$9.9M
Customers
1.5M
Curated content • Fact-checked and verified
Loading News...
Loading Culture...

Open Positions

Reddit Discussions

Loading Competitive Intelligence...

Key Differentiators

Emerging Innovator

Clinikally is an emerging player bringing innovative solutions to the Healthcare market.

Massive User Base

Trusted by 1.5M worldwide, demonstrating broad market appeal and proven reliability.

Frequently Asked Questions

Not So Random Others

Brisk

Consumer Food & Beverage
B2cManufacturingNorth AmericaFortune500

Brisk is a functional beverage brand offering ready-to-drink iced tea and juice drinks, jointly owned by PepsiCo and Unilever under the Lipton brand partnership. Launched in the 1990s, Brisk positione

Altria

Consumer Goods
B2cManufacturingNorth AmericaPublicFortune500

Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and s

Hermes Robotics

Manufacturing
B2bHardwareManufacturingAi PoweredAutomationStartup

Hermes Robotics is an autonomous mobile robot (AMR) and warehouse automation company developing robots and software for logistics and fulfillment operations in warehouses, distribution centers, and ma

Duckie

Infrastructure
B2bPlatformAi PoweredAutomation

Duckie is a San Francisco-based AI customer support platform — backed by Y Combinator (W24) with $500,000 in funding from Y Combinator, Andreessen Horowitz, Greylock, KungHo Fund, Netflix, and 5 addit

Zeffy

Nonprofit Tech
B2bSaas

Zeffy is a Montreal-based fundraising platform for nonprofit organizations that charges zero platform fees on donations — asking donors to optionally contribute a tip to cover Zeffy's operating costs

Oda Studio

Real Estate & Property Tech
B2bProptechAi PoweredSaas

Oda Studio is a United States-based AI-powered interior design platform — backed by Y Combinator (W20) — providing homebuyers, renters, and design enthusiasts with AI tools to discover their personal

Compare Clinikally with Competitors

Side-by-side AI visibility scores, platform breakdown, and market position.

For Clinikally

Claim This Profile

Are you from Clinikally? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.

Claim Clinikally Profile →
For competitors & analysts

Track AI Visibility in Real Time

Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Clinikally vs competitors. Get alerts when AI recommendations shift.

Start Free Tracking →